Nurse Practitioner, Family · Nashville, TN
NPI
1386766194
Since 2007
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
719 Thompson Ln, 37189
Nashville, TN, 37204
Phone (615) 875-5111
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,369
332 services
Medicare patients, 2024
38
Average age 62
Drug cost, 2024
$5.9M
3,258 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kehinde A Eguakun was code 99215 (office e&m - established), 34 times for 22 patients. In total Kehinde A Eguakun billed 332 services in 22 codes, and Medicare paid $8,369.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 34 | 22 | $83.79 | $2,849 |
| 99214 Office E&M - Established | Office | 19 | 14 | $65.49 | $1,244 |
| 46601 Digestive/Gastrointestinal | Office | 11 | 11 | $53.43 | $588 |
| G0008 Administration of influenza virus vaccine | Office | 11 | 11 | $29.78 | $328 |
By year: 2022 $5,244 for 116 services; 2023 $6,619 for 114 services; 2024 $8,369 for 332 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kehinde A Eguakun prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 416 prescriptions and refills. In total Kehinde A Eguakun wrote 3,258 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 416 | 434 | 58 | $1.8M |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 289 | 297 | 34 | $1.1M |
| Tivicay Dolutegravir Sodium | 268 | 268 | 29 | $606K |
| Descovy Emtricitabine/Tenofov Alafenam | 157 | 157 | 16 | $341K |
| Prezcobix Darunavir/Cobicistat | 153 | 161 | 15 | $387K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 138 | 138 | 16 | $677K |
| Atorvastatin Calcium Generic | 129 | 251 | 37 | $558 |
| Pravastatin Sodium Generic | 127 | 215 | 27 | $1,154 |
| Amlodipine Besylate Generic | 84 | 150 | 17 | $238 |
| Rosuvastatin Calcium Generic | 76 | 126 | 15 | $929 |
| Lisinopril Generic | 67 | 109 | 12 | $213 |
| Pifeltro Doravirine | 61 | 61 | Under 11 | $105K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 56 | 66 | Under 11 | $264K |
| Hydrochlorothiazide Generic | 55 | 85 | Under 11 | $149 |
| Tamsulosin Hcl Generic | 52 | 104 | 11 | $362 |
Brand drugs: 1,825 claims; generic drugs: 1,422 claims; opioid claims: 13.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kehinde A Eguakun were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.